Zobrazeno 1 - 10
of 383
pro vyhledávání: '"Oordt, P."'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Hutchison’s niche theory suggests that coexisting competing species occupy non-overlapping hypervolumes, which are theoretical spaces encompassing more than three dimensions, within an n-dimensional space. The analysis of multiple stable i
Externí odkaz:
https://doaj.org/article/133b78d3b1d7416587027a01230f4fc9
Autor:
Jessica E. Wijngaarden, Yvonne W. S. Jauw, Gerben J. C. Zwezerijnen, Berlinda J. de Wit-van der Veen, Daniëlle J. Vugts, Josée M. Zijlstra, Guus A. M. S. van Dongen, Ronald Boellaard, C. Willemien Menke-van der Houven van Oordt, Marc C. Huisman
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Background Distribution of mAbs into tumour tissue may occur via different processes contributing differently to the 89Zr-mAb uptake on PET. Target-specific binding in tumours is of main interest; however, non-specific irreversible uptake ma
Externí odkaz:
https://doaj.org/article/e2826c2a0dcd4ad8b44c5b0685c08e6a
Autor:
Jessica E. Wijngaarden, Amina Ahbari, Johanna E. E. Pouw, Henri N. J. M. Greuter, Idris Bahce, Gerben J. C. Zwezerijnen, Daniëlle J. Vugts, Guus A. M. S. van Dongen, Ronald Boellaard, C. Willemien Menke-van der Houven van Oordt, Marc C. Huisman
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-9 (2024)
Abstract Background PET scans using zirconium-89 labelled monoclonal antibodies (89Zr-mAbs), known as 89Zr-immuno-PET, are made to measure uptake in tumour and organ tissue. Uptake is related to the supply of 89Zr-mAbs in the blood. Measuring activit
Externí odkaz:
https://doaj.org/article/94a232ec570a4e688f5d66db698daa4a
Autor:
Tanja D de Gruijl, Rieneke van de Ven, K Hakki Karagozoglu, Pim de Graaf, Ronald Boellaard, Ruud H Brakenhoff, C René Leemans, Gerben J C Zwezerijnen, C Willemien Menke-van der Houven van Oordt, Iris H C Miedema, Niels E Wondergem, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Elisabeth Bloemena
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Addition of neoadjuvant immune checkpoint inhibition to standard-of-care interventions for locally advanced oral cancer could improve clinical outcome.Methods In this study, 16 evaluable patients with stage III/IV oral cancer were treated
Externí odkaz:
https://doaj.org/article/3a0f349d6bd74bb79ff5d9ffc2077cbb
Autor:
Tanja D de Gruijl, Rieneke van de Ven, Geke A P Hospers, Marc C Huisman, Gerben J C Zwezerijnen, C Willemien Menke-van der Houven van Oordt, Iris H C Miedema, Johanna E. E. Pouw, Anne Kwakman, Florentine E F Timmer, Adrianus J de Langen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)
Introduction Immune checkpoint inhibitors (ICIs) can elicit anticancer immune responses, but predictive biomarkers are needed. We measured programmed death ligand 1 (PD-L1) expression in organs and lymph nodes using 18F-BMS-986192 positron emission t
Externí odkaz:
https://doaj.org/article/25fc274b5a5a47a2b15beea98d6e7ced
Autor:
Jakoba J. Eertink, Idris Bahce, John C. Waterton, Marc C. Huisman, Ronald Boellaard, Andreas Wunder, Andrea Thiele, Catharina W. Menke-van der Houven van Oordt
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Immune-based treatment approaches are successfully used for the treatment of patients with cancer. While such therapies can be highly effective, many patients fail to benefit. To provide optimal therapy choices and to predict treatment responses, rel
Externí odkaz:
https://doaj.org/article/b1a23010f6ce4bedaedce8f56d996948
Autor:
Magdalena Mileva, Elisabeth G. E. de Vries, Thomas Guiot, Zéna Wimana, Anne-Leen Deleu, Carolien P. Schröder, Yolene Lefebvre, Marianne Paesmans, Sigrid Stroobants, Manon Huizing, Philippe Aftimos, Jolien Tol, Winette T. A. Van der Graaf, Wim J. G. Oyen, Danielle J. Vugts, C. Willemien Menke-van der Houven van Oordt, Adrienne H. Brouwers, Martine Piccart-Gebhart, Patrick Flamen, Géraldine Gebhart
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Efficacy of the human epidermal growth factor receptor (HER)2-targeting trastuzumab emtansine (T-DM1) in breast cancer (BC) relies on HER2 status determined by immunohistochemistry or fluorescence in-situ hybridization. Heterogeneity in HER2
Externí odkaz:
https://doaj.org/article/b8159ecb1674471b9a212c77843626e6
Autor:
Tanja D de Gruijl, Teodora Radonic, Marc C Huisman, Idris Bahce, Johanna E E Pouw, Sayed M S Hashemi, Jessica E Wijngaarden, Maarten Slebe, Daniela E Oprea-Lager, Gerben J C Zwezerijnen, Danielle Vugts, Ezgi B Ulas, Suresh Senan, C Willemien Menke-van der Houven van Oordt
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 2 (2024)
Background In patients with locally advanced unresectable non-small cell lung cancer (NSCLC), durvalumab, an anti-programmed cell death ligand-1 (PD-L1) antibody, has shown improved overall survival when used as consolidation therapy following concur
Externí odkaz:
https://doaj.org/article/4b3a18abdb6f4a34986c4c57af3d9db7
Autor:
Anouk Oordt-Speets, Julia Spinardi, Carlos Mendoza, Jingyan Yang, Graciela Morales, John M. McLaughlin, Moe H. Kyaw
Publikováno v:
COVID, Vol 3, Iss 10, Pp 1516-1527 (2023)
Vaccination against infectious disease affords direct protection from vaccine-induced immunity and additional indirect protection for unvaccinated persons. A systematic review was conducted to estimate the indirect effect of COVID-19 vaccination. Fro
Externí odkaz:
https://doaj.org/article/ceedf187be1c4d9eabd29999ece878a4
Autor:
Yasmin A. Civil, Arlene L. Oei, Katya M. Duvivier, Nina Bijker, Philip Meijnen, Lorraine Donkers, Sonja Verheijen, Zdenko van Kesteren, Miguel A. Palacios, Laura J. Schijf, Ellis Barbé, Inge R. H. M. Konings, C. Willemien Menke -van der Houven van Oordt, Paulien G. Westhoff, Hanneke J. M. Meijer, Gwen M. P. Diepenhorst, Victor Thijssen, Florent Mouliere, Berend J. Slotman, Susanne van der Velde, H. J. G. Desirée van den Bongard
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Partial breast irradiation (PBI) is standard of care in low-risk breast cancer patients after breast-conserving surgery (BCS). Pre-operative PBI can result in tumor downstaging and more precise target definition possibly resulting
Externí odkaz:
https://doaj.org/article/dc6a0f20cb054375986fc9996c89d8ed